allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56...

FDA Recall #D-0909-2023 — Class II — February 9, 2023

Recall #D-0909-2023 Date: February 9, 2023 Classification: Class II Status: Terminated

Product Description

allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39); and b) 45-count cartons (NDC 56062-847-95), Distributed by: Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811.

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

L. Perrigo Company — Allegan, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

32,904 cartons

Distribution

Nationwide within the USA

Code Information

Lot #: a) 2CR0652, 2DR0464, 2DR0465,Exp. Date 12/23; 2ER0285, Exp. Date 01/24. b) 2DR0466, Exp. Date 12/23; 2ER0412, Exp. Date 01/24; 2GR0330, Exp. Date 04/24

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated